Literature DB >> 21479549

Development of an online SPE-LC-MS-based assay using endogenous substrate for investigation of soluble epoxide hydrolase (sEH) inhibitors.

Nils Helge Schebb1, Marion Huby, Christophe Morisseau, Sung Hee Hwang, Bruce D Hammock.   

Abstract

Soluble epoxide hydrolase (sEH) is a promising therapeutic target for the treatment of hypertension, pain, and inflammation-related diseases. In order to enable the development of sEH inhibitors (sEHIs), assays are needed for determination of their potency. Therefore, we developed a new method utilizing an epoxide of arachidonic acid (14(15)-EpETrE) as substrate. Incubation samples were directly injected without purification into an online solid phase extraction (SPE) liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS-MS) setup allowing a total run time of only 108 s for a full gradient separation. Analytes were extracted from the matrix within 30 s by turbulent flow chromatography. Subsequently, a full gradient separation was carried out on a 50X2.1 mm RP-18 column filled with 1.7 μm core-shell particles. The analytes were detected with high sensitivity by ESI-MS-MS in SRM mode. The substrate 14(15)-EpETrE eluted at a stable retention time of 96 ± 1 s and its sEH hydrolysis product 14,15-DiHETrE at 63 ± 1 s with narrow peak width (full width at half maximum height: 1.5 ± 0.1 s). The analytical performance of the method was excellent, with a limit of detection of 2 fmol on column, a linear range of over three orders of magnitude, and a negligible carry-over of 0.1% for 14,15-DiHETrE. The enzyme assay was carried out in a 96-well plate format, and near perfect sigmoidal dose-response curves were obtained for 12 concentrations of each inhibitor in only 22 min, enabling precise determination of IC(50) values. In contrast with other approaches, this method enables quantitative evaluation of potent sEHIs with picomolar potencies because only 33 pmol L(-1) sEH were used in the reaction vessel. This was demonstrated by ranking ten compounds by their activity; in the fluorescence method all yielded IC(50) ≤ 1 nmol L(-1). Comparison of 13 inhibitors with IC(50) values >1 nmol L(-1) showed a good correlation with the fluorescence method (linear correlation coefficient 0.9, slope 0.95, Spearman's rho 0.9). For individual compounds, however, up to eightfold differences in potencies between this and the fluorescence method were obtained. Therefore, enzyme assays using natural substrate, as described here, are indispensable for reliable determination of structure-activity relationships for sEH inhibition.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21479549      PMCID: PMC3081056          DOI: 10.1007/s00216-011-4861-2

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  35 in total

1.  Comparative study of new shell-type, sub-2 micron fully porous and monolith stationary phases, focusing on mass-transfer resistance.

Authors:  Erzsébet Oláh; Szabolcs Fekete; Jeno Fekete; Katalin Ganzler
Journal:  J Chromatogr A       Date:  2010-04-02       Impact factor: 4.759

2.  Electrochemistry-mass spectrometry unveils the formation of reactive triclocarban metabolites.

Authors:  A Baumann; W Lohmann; T Rose; K C Ahn; B D Hammock; U Karst; N H Schebb
Journal:  Drug Metab Dispos       Date:  2010-09-22       Impact factor: 3.922

3.  Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors.

Authors:  Sung Hee Hwang; Christophe Morisseau; Zung Do; Bruce D Hammock
Journal:  Bioorg Med Chem Lett       Date:  2006-09-01       Impact factor: 2.823

4.  Development of a high-throughput screen for soluble epoxide hydrolase inhibition.

Authors:  Nicola M Wolf; Christophe Morisseau; Paul D Jones; Bertold Hock; Bruce D Hammock
Journal:  Anal Biochem       Date:  2006-05-11       Impact factor: 3.365

5.  Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs.

Authors:  Hsing-Ju Tsai; Sung Hee Hwang; Christophe Morisseau; Jun Yang; Paul D Jones; Takeo Kasagami; In-Hae Kim; Bruce D Hammock
Journal:  Eur J Pharm Sci       Date:  2010-03-30       Impact factor: 4.384

Review 6.  Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs).

Authors:  Bora Inceoglu; Kara R Schmelzer; Christophe Morisseau; Steve L Jinks; Bruce D Hammock
Journal:  Prostaglandins Other Lipid Mediat       Date:  2006-07-05       Impact factor: 3.072

7.  Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry.

Authors:  Cara Polson; Pratibha Sarkar; Bev Incledon; Vanaja Raguvaran; Russell Grant
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-03-05       Impact factor: 3.205

8.  Development of a liquid chromatography-based screening methodology for proteolytic enzyme activity.

Authors:  Nils Helge Schebb; Torsten Vielhaber; Alexandre Jousset; Uwe Karst
Journal:  J Chromatogr A       Date:  2009-03-25       Impact factor: 4.759

9.  Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis.

Authors:  D C Zeldin; S Wei; J R Falck; B D Hammock; J R Snapper; J H Capdevila
Journal:  Arch Biochem Biophys       Date:  1995-01-10       Impact factor: 4.013

10.  Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways.

Authors:  Bora Inceoglu; Steven L Jinks; Arzu Ulu; Christine M Hegedus; Katrin Georgi; Kara R Schmelzer; Karen Wagner; Paul D Jones; Christophe Morisseau; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-21       Impact factor: 11.205

View more
  10 in total

1.  In vitro glucuronidation of the antibacterial triclocarban and its oxidative metabolites.

Authors:  N H Schebb; B Franze; R Maul; A Ranganathan; B D Hammock
Journal:  Drug Metab Dispos       Date:  2011-09-27       Impact factor: 3.922

2.  Whole blood is the sample matrix of choice for monitoring systemic triclocarban levels.

Authors:  Nils Helge Schebb; Ki Chang Ahn; Hua Dong; Shirley J Gee; Bruce D Hammock
Journal:  Chemosphere       Date:  2012-01-23       Impact factor: 7.086

3.  t-AUCB, an improved sEH inhibitor, suppresses human glioblastoma cell growth by activating NF-κB-p65.

Authors:  Junyang Li; Hongyi Liu; Biao Xing; Yanzhe Yu; Hui Wang; Gong Chen; Bing Gu; Guofeng Zhang; Dong Wei; Peiyuan Gu; Meng Li; Weixing Hu
Journal:  J Neurooncol       Date:  2012-03-02       Impact factor: 4.130

4.  Metabolism of the antibacterial triclocarban by human epidermal keratinocytes to yield protein adducts.

Authors:  Nils Helge Schebb; Bruce A Buchholz; Bruce D Hammock; Robert H Rice
Journal:  J Biochem Mol Toxicol       Date:  2012-06       Impact factor: 3.642

5.  Bioconcentration, metabolism and excretion of triclocarban in larval Qurt medaka (Oryzias latipes).

Authors:  Nils Helge Schebb; Ida Flores; Tomofumi Kurobe; Bastian Franze; Anupama Ranganathan; Bruce D Hammock; Swee J Teh
Journal:  Aquat Toxicol       Date:  2011-08-04       Impact factor: 4.964

6.  Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern.

Authors:  Annika I Ostermann; Jan Herbers; Ina Willenberg; Rongjun Chen; Sung Hee Hwang; Robert Greite; Christophe Morisseau; Faikah Gueler; Bruce D Hammock; Nils Helge Schebb
Journal:  Prostaglandins Other Lipid Mediat       Date:  2015-06-25       Impact factor: 3.072

7.  Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive.

Authors:  Oscar Sasso; Karen Wagner; Christophe Morisseau; Bora Inceoglu; Bruce D Hammock; Daniele Piomelli
Journal:  Pharmacol Res       Date:  2015-04-14       Impact factor: 7.658

8.  Development of On-line Liquid Chromatography-Biochemical Detection for Soluble Epoxide Hydrolase Inhibitors in Mixtures.

Authors:  David Falck; Nils Helge Schebb; Setyo Prihatiningtyas; Jiawen Zhang; Ferry Heus; Christophe Morisseau; Jeroen Kool; Bruce D Hammock; Wilfried M A Niessen
Journal:  Chromatographia       Date:  2012-11-07       Impact factor: 2.044

9.  Förster resonance energy transfer competitive displacement assay for human soluble epoxide hydrolase.

Authors:  Kin Sing Stephen Lee; Christophe Morisseau; Jun Yang; Peng Wang; Sung Hee Hwang; Bruce D Hammock
Journal:  Anal Biochem       Date:  2012-12-05       Impact factor: 3.365

10.  Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy.

Authors:  Kin Sing Stephen Lee; Jun-Yan Liu; Karen M Wagner; Svetlana Pakhomova; Hua Dong; Christophe Morisseau; Samuel H Fu; Jun Yang; Peng Wang; Arzu Ulu; Christina A Mate; Long V Nguyen; Sung Hee Hwang; Matthew L Edin; Alexandria A Mara; Heike Wulff; Marcia E Newcomer; Darryl C Zeldin; Bruce D Hammock
Journal:  J Med Chem       Date:  2014-08-11       Impact factor: 7.446

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.